ENDERSON, NV--(Marketwired - Dec 22, 2015) - Rx Safes, Inc. (OTCQB: RXSF), the developer of patented autonomous fingerprint healthcare security products announced today that it has released the company's first commissioned research report that highlights the company's products, analyzes the specific healthcare sub-markets its products are designed for, and has an outperform rating with a 2016 targeted share price of $17.41.
100k GNID Shares = $1,741,000
300k GNID Shares = $5,223,000
600k GNID Shares = $10,446,000
Happy New Year!!!!!!!!!!!
Invest in yourself. Control your own Destiny.